# Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy

> **NCT04039516** · PHASE2 · UNKNOWN · sponsor: **King's College Hospital NHS Trust** · enrollment: 20 (estimated)

## Conditions studied

- Carcinoid Heart Disease
- Carcinoid Syndrome
- Carcinoid Tumor

## Interventions

- **DRUG:** Lutathera

## Key facts

- **NCT ID:** NCT04039516
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04039516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04039516, "Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04039516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*